Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

Share Price is delayed by 15 minutes
Get Live Data
76.70    -1.50 (-1.92%)
Bid:
76.90
Ask:
77.80
Spread: 0.90 (1.17%)
Market Cap: £623.43m
GCP Live PriceLast checked at - London Stock Exchange

Intraday GCP Infrastructure Investments Share Chart

Conditional investment commitment

20 Apr 2017 10:18

RNS Number : 8551C
GCP Infrastructure Investments Ltd
20 April 2017
 

20 April 2017

 

GCP Infrastructure Investments Limited ("GCP Infrastructure" or "the Company")

Conditional investment commitment in connection with the sale of the UK Green Investment Bank plc

The Board of GCP Infrastructure, the only listed infrastructure fund focused primarily on investment in UK infrastructure debt, notes the announcement by Macquarie Group ("Macquarie") today in respect of its acquisition of the UK Green Investment Bank plc (the "GIB Transaction").

The Board confirms that the Company has entered into a conditional, binding commitment with a Macquarie-owned entity to subscribe for a series of loan notes with a value of up to c. £140 million, in aggregate, over a c. two year period (the "GIB Loan Notes"). The proceeds of the GIB Loan Notes, if issued, will be used to purchase and/or finance investments secured against 23 UK based projects (the "Projects") connected to the GIB Transaction.

Each of the Projects is in receipt of, or is expected to be in receipt of, revenues arising from either government-backed public-private partnership ("PPP") schemes or government-sponsored mechanisms for promoting energy efficiency or renewable electricity generation in the UK. The Projects involve developments across multiple sectors including waste to energy, onshore wind, hydro, landfill gas and building retrofit schemes.

This commitment by the Company extends the existing relationship with the UK Green Investment Bank plc (the "GIB"), which has seen the Company invest alongside the GIB in a number of projects over the last four years. The Company intends to continue to work with the GIB, under Macquarie's ownership, to ensure the long-term success of the Projects and to explore further opportunities in sectors of the green economy relevant to its investment mandate.

The Company's conditional investment is subject, inter alia, to regulatory approval of the GIB Transaction. The GIB Transaction is currently expected to complete in the first half of 2017.

The acquisition of the GIB Loan Notes, if issued, will be funded by the Company from its available resources at the relevant time.

A further announcement will be made in due course.

Contact details:

Gravis Capital Management Ltd

Phil Kent

Stephen Ellis

 

+44 (0)20 7518 1490

Stifel Nicolaus Europe Limited

Neil Winward

Mark Bloomfield

Tunga Chigovanyika

+44 (0)20 7710 7600

Buchanan

Charles Ryland

Victoria Watkins

+44 (0)20 7466 5000

 

Notes to Editors

The Company

The Company is a closed-ended London Stock Exchange-listed investment company that seeks to generate returns from senior and subordinated infrastructure debt and related and/or similar assets. The Company is advised by Gravis Capital Management Ltd.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIMMLTMBBTMAR
Date   Source Headline
26th Apr 20222:32 pmRNSHolding(s) in Company
25th Apr 20227:00 amRNSDirector/PDMR Shareholding
21st Apr 202211:26 amRNSDividend Declaration & Scrip Dividend Alternative
14th Apr 20224:12 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSNet Asset Value(s)
31st Mar 20227:00 amRNSTotal Voting Rights
8th Mar 20229:46 amRNSAdditional Listing and Total Voting Rights
24th Feb 20229:25 amRNSAdditional Listing
21st Feb 20227:00 amRNSDirector Declaration
14th Feb 20223:03 pmRNSResult of AGM
26th Jan 20221:26 pmRNSDirector/PDMR Shareholding
26th Jan 20221:24 pmRNSDirector/PDMR Shareholding
21st Jan 202212:10 pmRNSDividend Declaration & Scrip Dividend Alternative
21st Jan 20227:00 amRNSInvestor Report at 31 December 2021
18th Jan 20223:31 pmRNSUpdate research from QuotedData
17th Jan 20227:00 amRNSNet Asset Value(s)
10th Jan 20228:00 amRNSNotice of AGM
31st Dec 20217:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSDirector Declaration
14th Dec 20217:00 amRNSAnnual report and financial statements
9th Dec 202110:39 amRNSDirector/PDMR Shareholding
9th Dec 20218:41 amRNSAdditional Listing and Total Voting Rights
1st Dec 20217:00 amRNSDirectorate Change
29th Nov 202110:09 amRNSAdditional Listing
11th Nov 20217:00 amRNSScrip Share Reference Price
29th Oct 20217:00 amRNSInvestor Report at 30 September 2021
28th Oct 20211:54 pmRNSDividend Declaration & Scrip Dividend Alternative
19th Oct 20217:00 amRNSNet Asset Value(s)
30th Sep 20217:00 amRNSTotal Voting Rights
17th Sep 20215:23 pmRNSNew Directorship Notification
9th Sep 202111:47 amRNSDirector/PDMR Shareholding
9th Sep 202111:47 amRNSAdditional Listing and Total Voting Rights
3rd Sep 20214:15 pmRNSNew Directorship Notification
27th Aug 202110:19 amRNSAdditional Listing
12th Aug 20217:00 amRNSScrip share reference price
9th Aug 202111:42 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSInvestor Report at 30 June 2021 and RCF update
28th Jul 20217:00 amRNSDividend Declaration & Scrip Dividend Alternative
20th Jul 202110:59 amRNSUpdate research from QuotedData
16th Jul 20219:21 amRNSDirector/PDMR Shareholding
15th Jul 20217:00 amRNSNet Asset Value(s)
1st Jul 202110:55 amRNSHolding(s) in Company
30th Jun 20217:00 amRNSTotal Voting Rights
22nd Jun 202110:20 amRNSDirector/PDMR Shareholding
21st Jun 20211:21 pmRNSDirector/PDMR Shareholding
10th Jun 20217:00 amRNSHalf-yearly report and financial statements 2021
8th Jun 202112:11 pmRNSDirector/PDMR Shareholding
8th Jun 20219:47 amRNSAdditional Listing and Total Voting Rights
28th May 20219:23 amRNSAdditional Listing
13th May 20217:00 amRNSScrip Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.